Apolipoprotein B gene variants are involved in the determination of blood glucose and lipid levels in patients with non-insulin dependent diabetes mellitus

Cell Biochemistry and Function

Volumn 24, Issue 3, 2006, Pages 261-267

  Duman, Belgin Süsleyici ^a   Öztürk, Melek ^b   Yilmazer, Selma ^b   Çaǧatay, Penbe ^b   Hatemi, Hüsrev ^b,c  

^a KADIR HAS UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Turkish Diabetes Hospital   (Turkey)

Author keywords

Apolipoprotein B; Non insulin dependent diabetes mellitus; Polymorphism

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; GENOMIC DNA; GLUCOSE; LIPID; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; APOLIPOPROTEINS E; BLOOD GLUCOSE; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DNA; FEMALE; HUMANS; LIPIDS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REFERENCE VALUES; TRIGLYCERIDES; VARIATION (GENETICS);

EID: 33646790855     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1218     Document Type: Article

References (51)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
2. Gonzelez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Perez BA. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas. Diabetes Care 1994; 17: 397-404.
3. Poulsen P, Vaag A, Kyvik K, Beck-Nielsen H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 2001; 44: 537-543.
4. Kahn CR. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43: 1066-1084.
5. Matsumoto K, Sakamaki H, Izumino K, et al. Increased insulin sensitivity and decreased insulin secretion in offspring of insulin-sensitive type 2 diabetic patients. Metabolism 2001; 49: 1219-1223.
6. Morton NE, Lio P. Oligogenic linkage and map integration. In Genetic Mapping of Disease Genes (1st edn), Pawlowitzki H, Edwards JH, Thompson EA (eds). Academic Press: San Diego, CA, 1997; 17-21.
7. De Meyts P. The diabetogenes concept of NIDDM. Adv Exp Med Biol 1993; 334: 89-100.
8. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
9. Houlston RS, Snowden C, Laker MF, Alberti KG, Humphries SE. Variation in the apolipoprotein B gene and development of type 2 diabetes mellitus. Dis Markers 1991; 9: 87-96.
10. Choong ML, Sethi SK, Koay ES. Effects of intragenic variability at 3 polymorphic sites of the apolipoprotein B gene on serum lipids and lipoproteins in a multiethnic Asian population. Hum Biol 1999; 71: 381-397.
11. Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998; 21: 160-178.
12. Taskinen MR. Hyperlipidaemia in diabetes. Baillieres Clin Endocrinol Metab 1990; 4: 743-775.
13. Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 1985; 110: 1100-1107.
14. Caixas A, Ordonez-Llanos I, de Leiva A, Payes A, Horns R, Perez A. Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes 1997; 46: 1207-1213.
15. Brown MS, Goldstein JL. How LDL receptors influence cholesterol and atherosclerosis. Sci Am 1984; 251: 58-66.
16. Knott TJ, Rall SC, Innerarity TL, et al. Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. Science 1985; 230: 37-43.
17. Xiang KS, Cox NJ, Sanz N, Huang P, Karam JH, Bell GI. Insulin-receptor and apolipoprotein genes contribute to development of NIDDM in Chinese Americans. Diabetes 1989; 38: 17-23.
18. Gutierrez C, Vendrell J, Broch M, et al. Apolipoprotein AI-CIII, B, and CII gene polymorphisms in patients with non-insulin dependent diabetes mellitus. Association with hyperlipemia. Med Clin (Barc) 1996; 107: 561-565.
19. Berg K, Hames C, Dahlen G, Frick MH, Krishan I. Genetic variation in serum low density lipoproteins and lipid levels in man. Proc Natl Acad Sci USA 1976; 73: 937-940.
20. Ma YH, Schumaker VN, Butler R, Sparkes RS. Two DNA restriction fragment length polymorphisms associated with Ag(t/z) and Ag(g/c) antigenic sites of human apolipoprotein B. Arteriosclerosis 1987; 7: 301-305.
21. Huang LS, de Graaf J, Breslow JL. ApoB gene MspI RFLP in exon 26 changes amino acid 3611 from Arg to Gln. J Lipid Res 1988; 29: 63-67.
22. Peacock R, Dunning A, Hamsten A, Tornvall P, Humphries S, Talmud P. Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: a study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 1992; 92: 151-164.
23. Renges HH, Peacock R, Dunning AM, Talmud P, Humphries SE. Genetic relationship between the 3′-VNTR and diallelic apolipoprotein B gene polymorphisms: haplotype analysis in individuals of European and south Asian origin. Ann Hum Genet 1992; 56: 11-33.
24. Law A, Wallis SC, Powell LM, et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1986; 1: 1301-1303.
25. Talmud PJ, Barni N, Kessling AM, et al. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis 1987; 67: 81-89.
26. Berg K. DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet 1986; 30: 515-520.
27. Gylling H, Kontula K, Koivisto UM, Miettinen HE, Miettinen TA. Polymorphisms of the genes encoding apoproteins A-I, B. C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact. Arterioscler Thromb Vasc Biol 1997; 17: 38-44.
28. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. World Health Organization: Geneva, 1999.
29. Arroyo P, Pardio J, Fernandez V, Vargas-Ancona L, Canul G, Loria A. Obesity and cultural environment in the Yucatan region. Nutr Rev 1999; 57: S78-S82.
30. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 1988; 16: 1215.
31. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491.
32. Iso H, Harada S, Shimamoto T, et al. Polymorphism of the apolipoprotein B gene and blood lipid concentrations in Japanese and Caucasian population samples. Atherosclerosis 1996; 126: 233-241.
33. Misra A, Nishanth S, Pasha ST, Pandey RM, Sethi P, Rawat DS. Relationship of Xba1 and EcoR1 polymorphisms of apolipoprotein-B gene to dyslipidemia and obesity in Asian Indians in North India. Indian Heart J 2001; 53: 177-183.
34. Horvath A, Chorbov V, Zaharova B, Ganev V. Five polymorphisms of the apolipoprotein B gene in healthy Bulgarians. Hum Biol 2003; 75: 69-80.
35. Chan L, Dresel H. Genetic factors influencing lipoprotein structure: implications for atherosclerosis. Lab Invest 1990; 62: 522-537.
36. Korhonen T, Savolainen MJ, Kesaniemi YA. Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia. Atherosclerosis 1999; 146: 1-10.
37. Delghandi M, Thangarajah R, Nilsen M, et al. 1999. DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and Mspl RFLPs) in Norwegians at risk of atherosclerosis and healthy controls. Acta Cardiol 1999; 54: 215-225.
38. Guzman EC, Hirata MH, Quintao EC, Hirata RD. Association of the apolipoprotein B gene polymorphisms with cholesterol levels and response to fluvastatin in Brazilian individuals with high risk for coronary heart disease. Clin Chem Lab Med 2000; 38: 731-736.
39. Machado MO, Hirata MH, Bertolami MC, Hirata RD. Apo B gene haplotype is associated with lipid profile of higher risk for coronary heart disease in Caucasian Brazilian men. J Clin Lab Anal 2001; 15: 19-24.
40. West KM, Ahuja MM, Bennett PH, et al. The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983; 6: 361-369.
41. Genest JJ Jr, Ordovas JM, McNamara JR, et al. DNA polymorphisms of the apolipoprotein B gene in patients with coronary artery disease. Atherosclerosis 1990; 82: 7-17.
42. Siest G, Henny J, Galteau MM, Schiele F, Steinmetz J, Visvikis S. Lipid and lipoprotein genetic variability: an important contribution from the French health examination centers. Clin Biochem 1995; 28: 31-38.
43. Howard BV, Lee ET, Fabsitz RR, et al. Diabetes and coronary heart disease in American Indians: the Strong Heart Study. Diabetes 1996; 45(Suppl. 3): S6-S13.
44. Puri RD, Tewari S, Sinha N, et al. Polymorphisms in the apolipoprotein B-100 gene: association with plasma lipid concentration and coronary artery disease. Indian Heart J 2003; 55: 60-64.
45. Ghusn H, Arem R, Frazier M, Chamakhi S, Ezzaouia G, Chan L. Restriction fragment length polymorphism of the human apo B and apo AII gene regions among type II diabetics. Res Commun Mol Pathol Pharmacol 1996; 93: 25-32.
46. Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kesaniemi YA. Apolipoprotein B gene DNA polymorphisms are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus. Clin Genet 1993; 44: 177-184.
47. Hong SH, Song J, Kim JQ. The haplotype analyses using multiple markers of the apolipoprotein B gene in patients with coronary artery disease. J Korean Med Sci 2001; 16: 719-724.
48. Hegele RA, Huang LS, Herbert PN, et al. Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 1986; 315: 1509-1515.
49. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Humphries SE. Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in Danes. Atherosclerosis 1991; 89: 69-81.
50. Deeb S, Failor A, Brown BG, Brunzell JD, Albers JJ, Motulsky AG. Molecular genetics of apolipoproteins and coronary heart disease. Cold Spring Harb Symp Quant Biol 1986; 51: 403-409.
51. Xu CF, Nanjee N, Tikkanen MJ, et al. Apolipoprotein B amino acid 3611 substitution from arginine to glutamine creates the Ag (h/i) epitope: the polymorphism is not associated with differences in serum cholesterol and apolipoprotein B levels. Hum Genet 1989: 82: 322-326.